The global microRNA (abbreviated miRNA) market size is expected to reach USD 626.27 million by 2025, according to a new report by Grand View Research, Inc., posting a CAGR of 18.6% during the forecast period. A significant role of microRNAs in regulating gene expression. Their rapid adoption in development of diagnostic & prognostic tools for various cancer types is anticipated to provide a fillip to the market.
Recent
innovations in miRNA applications such as their use as potential biomarkers in
advanced diagnostics have accelerated new product development. Based on
existing technologies used in gene analysis such as microarrays, qRT-PCR, and
sequencing, new products are being developed for better usage of miRNA. These
are designed to overcome challenges faced when working with miRNA.
Investments
in development of therapeutics & diagnostic tests based on miRNAs have
increased tremendously over past few years. Regulus Therapeutics, Rosetta
Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics
are some major companies involved in the development of RNA-based therapeutics.
These players are involved in strategic partnerships to enhance their
capabilities. For instance, in February 2018, STA Pharmaceutical Co., Ltd., a
manufacturer of technology platform for small molecule pharmaceutical
development signed an agreement with Regulus Therapeutics to provide its
manufacturing facility to the company.
Academic
& government research organizations are key revenue contributors as large
number of microRNA research is carried out in these institutes. However, rising
interest of biotech & pharmaceutical companies in miRNAs as biomarkers,
especially in cancer screening, is providing a significant push to the market.
MiRNA regulating gene expressions in Alzheimer’s diseases, Autism Spectrum
Disorders (ASD), Schizophrenia, and Parkinson’s diseases have been identified.
Soaring need for easy diagnosis of these diseases is projected to further
increase demand for miRNA research tools.
Instruments
used in miRNA analysis, especially those based on advanced technology, are
expensive. However, processes performed are available at reasonable prices
through service providers. MiRNA analysis is a part of genomic analysis,
thereby many service providers for the genomics market have extended their
service offering to this market as well. Novel approaches for handling targeted
delivery of miRNAs are being developed. Nanoparticle-based delivery and miRNA
conjugation with other small molecules are few of the potential approaches being
studied. Focus on development of approaches to overcome challenges in the
delivery of miRNA therapeutics is estimated to propel the market over the
forecast period.
Full Research Report On MicroRNA Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/microrna-market
Further Key
Findings from the Report Suggest:
- Growing competition among
miRNA-based therapeutic companies to develop tests & biomarkers for
clinical use is likely to boost the demand for miRNA detection services
- Rapid high-quality results
coupled with declining sequencing prices are poised to drive adoption of
NGS services for miRNA functional studies.
- North America dominated the
microRNA market owing to presence of large scale genetic research programs
being conducted by universities in the U.S. and Canada. MiRNA profiling
studies in these regions are supported by international public functional
genomic data repositories such as Gene Expression Omnibus
- Asia Pacific is projected to
witness phenomenal CAGR owing to rapid progress in precision medicine
& genomics. Owing to the immense potential in APAC, international
players are adopting M&A strategies to consolidate their position in
the region
- The market is moderately
consolidated and competitive in nature due to presence of several
multinational players
- Some key companies present
in the market are Thermofisher Scientific (Life Technologies); Agilent
Technologies; Merck KGaA; QIAGEN (Exiqon); and NanoString Technologies;
Inc. The prominence of these players can be attributed to their
well-established technical capabilities in other fields of biotechnology.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/microrna-market/request/rs1
Grand View Research has segmented
the global microRNA market on the basis of research scope, application,
end-use, and region:
MicroRNA Research
Tools Outlook (Revenue, USD Million, 2014 - 2025)
- Services
- Sample collection
- Whole Blood
- Serum
- Plasma
- miRNA cDNA Synthesis
- Profiling &
Purification
- Detection
- Functional Studies
- NGS
- Microarray
- Real Time PCR
- Others
- Products
- Instruments
- Kits, Reagents, &
Consumables
- Isolation &
Purification
- Quantification &
Detection
- Functional Analysis
- Others
MicroRNA
Application Outlook (Revenue, USD Million, 2014 - 2025)
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
MicroRNA End-use
Outlook (Revenue, USD Million, 2014 - 2025)
- Biotechnology and
Pharmaceutical Companies
- Academic & Government
Research Institutes
- Others
MicroRNA Regional
Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment